CD8+ T cells that co-express RORγt and T-bet are functionally impaired and expand in patients with distal bile duct cancer

被引：0

作者：

Chelappa, S. ^{[1
,2
,3
,4
]}

Hugenschmidt, H. ^{[5
,6
]}

Hagness, M. ^{[7
]}

Line, P. D. ^{[7
]}

Labori, K. -J ^{[8
]}

Wiedswang, G. ^{[9
]}

Tasken, K. ^{[1
,2
,3
,4
]}

Aandahl, E. M. ^{[1
,2
,3
,4
,7
]}

机构：

[1] Univ Oslo, Oslo, Norway

[2] Oslo Univ Hosp, Ctr Mol Med Norway, Nord EMBL Partnership, Oslo, Norway

[3] Univ Oslo, Ctr Biotechnol, KG Jebsen Ctr Inflammat Res, Oslo, Norway

[4] Univ Oslo, KG Jebsen Ctr Canc Immunotherapy, Oslo, Norway

[5] Oslo Univ Hosp, Sect Transplantat Surg, Oslo, Norway

[6] Oslo Univ Hosp, Dept Hepatopancreatobiliary Surg, Oslo, Norway

[7] Rigshosp, Oslo Univ Hosp, Sect Transplantat Surg, Oslo, Norway

[8] Oslo Univ Hosp, Dept Hepatopancreatobiliary Surg, Oslo, Norway

[9] Oslo Univ Hosp, Dept Gastrointestinal Surg, Oslo, Norway

来源：

EUROPEAN JOURNAL OF IMMUNOLOGY | 2016年 / 46卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

4203

引用

页码：859 / 860

页数：2

共 50 条

[21] Encephalitogenic T cells that stably express both T-bet and RORγt consistently produce IFNγ but have a spectrum of IL-17 profiles
Abromson-Leeman, Sara
Bronson, Roderick T.
Dorf, Martin E.
JOURNAL OF NEUROIMMUNOLOGY, 2009, 215 (1-2) : 10 - 24
[22] Effector/memory CD4 T cells making either Th1 or Th2 cytokines commonly co-express T-bet and GATA-3
Das, Arundhoti
Ranganathan, Vidya
Umar, Danish
Thukral, Shipra
George, Anna
Rath, Satyajit
Bal, Vineeta
PLOS ONE, 2017, 12 (10):
[23] Checkpoint Blockade Immunotherapy Relies on T-bet but Not Eomes to Induce Effector Function in Tumor-Infiltrating CD8+ T Cells
Berrien-Elliott, Melissa M.
Yuan, Jinyun
Swier, Lauryn E.
Jackson, Stephanie R.
Chen, Collin L.
Donlin, Maureen J.
Teague, Ryan M.
CANCER IMMUNOLOGY RESEARCH, 2015, 3 (02) : 116 - 124
[24] Oligoclonality of CD8+ T Cells in Breast Cancer Patients
Koichi Ito
James Fetten
Houman Khalili
Steven Hajdu
Erna Busch
Robert Pergolizzi
Vincent Vinciguerra
Ming-der Y. Chang
Molecular Medicine, 1997, 3 : 836 - 851
[25] Oligoclonality of CD8+ T cells in breast cancer patients
Ito, K
Fetten, J
Khalili, H
Hajdu, S
Busch, E
Pergolizzi, R
Vinciguerra, V
Chang, MDY
MOLECULAR MEDICINE, 1997, 3 (12) : 836 - 851
[26] Cyclosporine A Inhibits the T-bet-Dependent Antitumor Response of CD8+ T Cells
Rovira, J.
Renner, P.
Sabet-Baktach, M.
Eggenhofer, E.
Koehl, G. E.
Lantow, M.
Lang, S. A.
Schlitt, H. J.
Campistol, J. M.
Geissler, E. K.
Kroemer, A.
AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (04) : 1139 - 1147
[27] Eomes+T-betlow CD8+ T Cells Are Functionally Impaired and Are Associated with Poor Clinical Outcome in Patients with Acute Myeloid Leukemia
Jia, Bei
Zhao, Chenchen
Rakszawski, Kevin L.
Claxton, David F.
Ehmann, W. Christopher
Rybka, Witold B.
Mineishi, Shin
Wang, Ming
Shike, Hiroko
Bayerl, Michael G.
Sivik, Jeffrey M.
Schell, Todd D.
Drabick, Joseph J.
Hohl, Raymond J.
Zheng, Hong
CANCER RESEARCH, 2019, 79 (07) : 1635 - 1645
[28] CD27low NK CELLS PROLONG ALLOGRAFT SURVIVAL IN MICE BY CONTROLLING ALLOREACTIVE CD8+ T-CELLS IN A T-BET DEPENDENT MANNER
Lantow, M.
Eggenhofer, E.
Sabet-Baktach, M.
Renner, P.
Rovira, J.
Koehl, G. E.
Schlitt, H. J.
Geissler, E. K.
Kroemer, A.
TRANSPLANT INTERNATIONAL, 2014, 27 : 5 - 5
[29] Role of nuclear localization in the regulation and function of T-bet and Eomes in exhausted CD8 T cells
McLane, Laura M.
Ngiow, Shin Foong
Chen, Zeyu
Attanasio, John
Manne, Sasikanth
Ruthel, Gordon
Wu, Jennifer E.
Staupe, Ryan P.
Xu, Wei
Amaravadi, Ravi K.
Xu, Xiaowei
Karakousis, Giorgos C.
Mitchell, Tara C.
Schuchter, Lynn M.
Huang, Alexander C.
Freedman, Bruce D.
Betts, Michael R.
Wherry, E. John
CELL REPORTS, 2021, 35 (06):
[30] T-bet expression in CD8+T cells associated with chronic hepatitis B virus infection
Fan, Rongshan
Lan, Yinghua
Chen, Jiwang
Huang, Yanxin
Yan, Qin
Jiang, Lisheng
Song, Shupeng
Li, Yongguo
VIROLOGY JOURNAL, 2016, 13

← 1 2 3 4 5 →